ArticleNature communications2024

FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma.

Yuanli Zhen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.